Yuyu Pharma Inc. (000225) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Yuyu Pharma Inc. (000225:KRX), powered by AI.

Current Price
₩3,875
P/E Ratio
1.1
Market Cap
8.8B
Sector
Healthcare
What is the Yuyu Pharma Inc. stock price forecast?

Yuyu Pharma Inc. is currently trading at ₩3,875. View real-time AI analysis on Alpha Lenz.

What is Yuyu Pharma Inc. insider trading activity?

View the latest insider trading data for Yuyu Pharma Inc. on Alpha Lenz.

What is Yuyu Pharma Inc.'s P/E ratio?

Yuyu Pharma Inc.'s P/E ratio is 1.1.

Yuyu Pharma Inc.

KRX · 000225
₩3,875+10(+0.26%)Market closedKRX regular session 09:00–15:30 KST
Ask about Yuyu Pharma Inc.'s future dividend policy...
Alpha Chat Insight

Yuyu Pharma Inc. trades at a P/E of 1.1 (undervalued) with modest ROE of 6.4%.

Ask for details

Company Overview

Yuyu Pharma Inc. is an established player in the healthcare industry, primarily engaged in the development, manufacture, and marketing of pharmaceutical products. The company's key function is to provide innovative treatments and therapeutic solutions, catering to various medical needs across sectors such as oncology, urology, and cardiovascular health. Yuyu Pharma Inc. also focuses on over-the-counter (OTC) medicines, enhancing accessibility for consumers seeking trusted healthcare products. With a commitment to research and development, the company continuously invests in discovering new drugs and improving existing formulations. This dedication not only strengthens their product portfolio but also reinforces their role as a pivotal entity in advancing public health care standards. Operating extensively within both local and international markets, Yuyu Pharma Inc. plays a significant role in the pharmaceutical supply chain, ensuring the availability of critical healthcare solutions worldwide. Founded in South Korea, the company leverages its strong regional roots while expanding its influence globally, contributing effectively to addressing diverse health challenges on a broad scale.

CEOMr. Wonsang Yu
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees254

Company Statistics

FY 2025

Profile

₩8,784,353,750Market Cap
₩140,884,666,970Revenue
2.27MShares Out
254Employees

Margins

38.29%Gross
12.10%EBITDA
7.82%Operating
6.73%Pre-Tax
6.47%Net

Valuation

1.08P/E
0.07P/B
0.06EV/Sales
1.09EV/EBITDA
1.18P/FCF

Growth (CAGR)

0.48%Rev 3Yr
7.50%Rev 5Yr
N/AOp Inc 3Yr
11.93%Op Inc 5Yr
N/ANet Inc 3Yr
30.46%Net Inc 5Yr

Returns

4.39%ROA
6.40%ROE
5.77%ROIC

Financial Health

₩29,090,832,970Cash & Cash Equivalents
₩37,588,392,430Net Debt
47.44%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Yuyu Pharma Inc. (ticker: 000225) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 254 employees. Market cap is $8.8B.

The current price is ₩3,875 with a P/E ratio of 1.08x and P/B of 0.07x.

ROE is 6.40% and operating margin is 7.82%. Annual revenue is $140.9B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Yuyu Pharma Inc. (000225) Stock Forecast 2026 ₩3,875 — Price, Financials & Analyst Targets | Alpha Lenz